Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
University of Southern California
Case Comprehensive Cancer Center
University of Arizona
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)